1,289
Views
15
CrossRef citations to date
0
Altmetric
Research Articles

Repurposing drugs and identification of inhibitors of integral proteins (spike protein and main protease) of SARS-CoV-2

, , &
Pages 6587-6602 | Received 21 Oct 2020, Accepted 02 Feb 2021, Published online: 16 Feb 2021

References

  • Abdullahi, M., Olotu, F. A., & Soliman, M. E. (2018). Allosteric inhibition abrogates dysregulated LFA-1 activation: Structural insight into mechanisms of diminished immunologic disease. Computational Biology and Chemistry, 73, 49–56. https://doi.org/10.1016/j.compbiolchem.2018.02.002
  • Babine, R. E., & Bender, S. L. (1997). Molecular recognition of proteinminus signLigand complexes: Applications to drug design. Chemical Reviews, 97(5), 1359–1472. https://doi.org/10.1021/cr960370z
  • Basconi, J. E., & Shirts, M. R. (2013). Effects of temperature control algorithms on transport properties and kinetics in molecular dynamics simulations. Journal of Chemical Theory and Computation, 9(7), 2887–2899.
  • Basu, A., Sarkar, A., & Maulik, U. (2020). Computational approach for the design of potential spike protein binding natural compounds in SARS- CoV2. Pharmacodynamics, 4, 1–22. https://doi.org/10.21203/rs.3.rs-33181/v1[Epub ahead of print].
  • Begley, D. J., & Brightman, M. W. (2011). Structural and functional aspects of the blood-brain barrier. Peptide Transport and Delivery into the Central Nervous System’, 61(5), 39–78.
  • Burley, S. K., Berman, H. M., Christie, C., Duarte, J. M., Feng, Z., Westbrook, J., Young, J., & Zardecki, C. (2018). RCSB Protein Data Bank: Sustaining a living digital data resource that enables breakthroughs in scientific research and biomedical education. Protein Science : A Publication of the Protein Society, 27(1), 316–330. https://doi.org/10.1002/pro.3331
  • Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., Li, X., Xia, J., Chen, N., Xiang, J., Yu, T., Bai, T., Xie, X., Zhang, L., Li, C., … Wang, C. (2020). A trial of lopinavir–ritonavir in adults hospitalized with severe COVID. New England Journal of Medicine, 382(19), 1787–1799. https://doi.org/10.1056/NEJMoa2001282
  • Centres for Disease Control and Prevention. (2020). Information for clinicians on therapeutic options for COVID-19 patients. Retrieved September 21, 2020, from https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html
  • Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., Xia, J., Yu, T., Zhang, X., & Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. The Lancet), 395(10223), 507–513. https://doi.org/10.1016/S0140-6736(20)30211-7
  • Chetty, S., Bhakat, S., Martin, A. J. M., & Soliman, M. E. S. (2016). Multi-drug resistance profile of PR20 HIV-1 protease is attributed to distorted conformational and drug binding landscape: Molecular dynamics insights. Journal of Biomolecular Structure & Dynamics, 34(1), 135–151. https://doi.org/10.1080/07391102.2015.1018326
  • da Silva, C. H. T. P., Campo, V. L., Carvalho, I., & Taft, C. A. (2006). Molecular modeling, docking and ADMET studies applied to the design of a novel hybrid for treatment of Alzheimer's disease. Journal of Molecular Graphics & Modelling, 25(2), 169–175. https://doi.org/10.1016/j.jmgm.2005.12.002
  • Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. https://doi.org/10.1038/srep42717
  • de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016). SARS and MERS: Recent insights into emerging coronaviruses. Nature Reviews Microbiology, 14(8), 523–534. https://doi.org/10.1038/nrmicro.2016.81
  • Gonnet, P. (2007). P-SHAKE: A quadratically convergent SHAKE. Journal of Computational Physics, 220(2), 740–747. https://doi.org/10.1016/j.jcp.2006.05.032
  • Grosdidier, A., Zoete, V., & Michielin, O. (2011). SwissDock, a protein-small molecule docking web service based on EADock DSS. Nucleic Acids Res, 39(suppl_2), W270–7. https://doi.org/10.1093/nar/gkr366
  • Hanwell, M. D., Curtis, D. E., Lonie, D. C., Vandermeerschd, T., Zurek, E., & Hutchison, G. R. (2012). Avogadro: An advanced semantic chemical editor, visualization, and analysis platform. Journal of Cheminformatics, 4(8), 1–17.
  • Heaney, R. P. (2001). Factors influencing the measurement of bioavailability, taking calcium as a model. The Journal of Nutrition, 131(4 Suppl), 1344S–1348S. https://doi.org/10.1093/jn/131.4.1344S
  • Hess, B. (2002). Convergence of sampling in protein simulations. Physical Review, 65(3), 031910. https://coronavirus.jhu.edu/map.html
  • Idowu, K., Ramharack, P., Nlooto, M., & Gordon, M. (2019). The pharmacokinetic properties of HIV-1 protease inhibitors: A computational perspective on herbal phytochemicals. Heliyon, 5(10), e02565.
  • Idowu, K., Ramharack, P., Nlooto, M., & Gordon, M. (2020). Molecular dynamic mechanism(s) of inhibition of bioactive antiviral phytochemical compounds targeting cytochrome P450 3A4 and P-glycoprotein. Journal of Biomolecular Structure and Dynamics, 3, 1221–1233.
  • Izaguirre, J. A., Catarello, D. P., Wozniak, J. M., & Skeel, R. D. (2001). Langevin stabilization of molecular dynamics. The Journal of Chemical Physics, 114(5), 2090–2098. https://doi.org/10.1063/1.1332996
  • Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., … Yang, H. (2020). Structure of Mpro from COVID-19 virus and discovery of its inhibitors. Nature, 582(7811), 289–293. https://doi.org/10.1038/s41586-020-2223-y
  • Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983). Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics, 79(2), 926–935. https://doi.org/10.1063/1.445869
  • Jun, L., Jiwan, G., Jinfang, Y., Sisi, S., Huan, Z., Shilong, F., Qi, Z., Xuanling, S., Qisheng, W., Linqi, Z., & Xinquan, W. (2020). Crystal structure of the 2019-1 nCoV spike receptor-binding domain bound with the ACE2 receptor. https://doi.org/10.1101/2020.02.19.956235
  • Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B. A., Wang, J., Yu, B., Zhang, J., & Bryant, S. H. (2016). PubChem substance and compound databases. Nucleic Acids Research, 44(D1), D1202–1213. https://doi.org/10.1093/nar/gkv951
  • Kremers, P. (2002). In vitro tests for predicting drug-drug interactions: The need for validated procedures. Pharmacology & Toxicology, 91(5), 209–217. https://doi.org/10.1034/j.1600-0773.2002.910501.x
  • Kumi, R. O., Soremekun, O. S., Issahaku, A. R., Fisayo, C. A., Olotu, A., & Soliman, M. E. S. (2020). Exploring the ring potential of 2,4-diaminopyrimidine derivatives towards the identification of novel caspase-1 inhibitors in Alzheimer’s disease therapy. Journal of molecular modeling, 26(68), 1–17.
  • Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., Xing, X., Xiang, N., Wu, Y., Li, C., Chen, Q., Li, D., Liu, T., Zhao, J., Liu, M., … Feng, Z. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England Journal of Medicine, 382(13), 1199–1207. https://doi.org/10.1056/NEJMoa2001316
  • Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2012). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 64, 4–17. https://doi.org/10.1016/j.addr.2012.09.019
  • Liu, C., Zhou, Q., Li, Y., Garner, L. V., Watkins, S. P., Carter, L. J., Smoot, J., Gregg, A. C., Daniels, A. D., Jervey, S., & Albaiu, D. (2020). Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases. ACS Central Science, 6(3), 315–331. https://doi.org/10.1021/acscentsci.0c00272
  • Maurya, V. K., Kumar, S., Bhatt, M. L. B., & Saxena, S. K. (2020). Therapeutic development and drugs for the treatment of COVID-19. Nature Public Health Emergency Collection, 109–126. https://doi.org/10.1007/978-981-15-4814-7_10
  • Nair, P. C., & Miners, J. O. (2014). Molecular dynamics simulations: From structure function relationships to drug discovery. In Silico Pharmacology, 2(4), 1–4.
  • Remko, M., Boháč, A., & Kováčiková, L. (2011). Molecular structure, pKa, lipophilicity, solubility, absorption, polar surface area, and blood brain barrier penetration of some antiangiogenic agents. Structural Chemistry, 22(3), 635–648. https://doi.org/10.1007/s11224-011-9741-z
  • Ren, Z., Yan, L., Zhang, N., Guo, Y., Yang, C., Lou, Z., & Rao, Z. (2013). The newly emerged SARS-Like coronavirus HCoV-EMC also has an "Achilles' heel": Current effective inhibitor targeting a 3C-like protease. Protein & Cell, 4(4), 248–250. 249. https://doi.org/10.1007/s13238-013-2841-3
  • Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). (2020, February 16–24). World Health Organisation.
  • Robert, I. F. (1993). Mechanism of action of hydroxychloroquine as antirheumatic drug. Seminar in Arthritis and Rheumatism, 23(2), 82–91.
  • Rodríguez-Morales, P., Alfonso, J., MacGregor, K., Kanagarajah, S., Patel, D. & Schlagenhauf, (2020). Going global – Travel and the 2019 novel coronavirus. Travel Medicine and Infectious Disease, 33, 2020.
  • Ryckaert, J. P., Ciccotti, G., & Berendsen, H. J. (1977). Numerical integration of the Cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. Journal of Computational Physics, 23(3), 327–341. https://doi.org/10.1016/0021-9991(77)90098-5
  • Seifert, E. (2014). OriginPro 9.1: Scientific data analysis and graphing software-software review. Journal of Chemical Information and Modeling, 54(5), 1552–1552. https://doi.org/10.1021/ci500161d
  • Senathilake, K., Samarakoon, S., & Tennekoon, K. (2020). Virtual screening of inhibitors against spike glycoprotein of 2019 novel corona virus: A drug repurposing approach. https://doi.org/10.20944/preprints202003.0042.v1)
  • Shen, M., Zhou, Y., Ye, J., Al-Maskri, A. A. A., Kang, Y., Zeng, S., & Cai, S. (2020). Recent advances and perspectives of nucleic acid detection for coronavirus. Journal of Pharmaceutical Analysis, 10(2), 97–101. https://doi.org/10.1016/j.jpha.2020.02.010
  • Sindhu, T., & Srinivasan, P. (2015). Exploring the binding properties of agonists interacting with human TGR5 using structural modelling, molecular docking and dynamics simulations. RSC Advances, 5(19), 14202–14213. https://doi.org/10.1039/C4RA16617E
  • St. John, S. E., Tomar, S., Stauffer, S. R., & Mesecar, A. D. (2015). Targeting zoonotic viruses: Structure-based inhibition of the 3C-like protease from bat coronavirus HKU4-The likely reservoir host to the human coronavirus that causes Middle East Respiratory Syndrome (MERS)). Bioorganic & Medicinal Chemistry, 23(17), 6036–6048. https://doi.org/10.1016/j.bmc.2015.06.039
  • Wang, F., Chen, C., Tan, W., Yang, K., & Yang, H. (2016). Structure of main protease from human coronavirus NL63: Insights for wide spectrum anti-coronavirus drug design. Scientific Reports, 6, 22677–22677. https://doi.org/10.1038/srep22677
  • Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research, 30(3), 269–271. https://doi.org/10.1038/s41422-020-0282-0
  • World Health Organization. (2020). Coronavirus disease 2019 (COVID-19): Situation report, 38. https://apps.who.int/iris/handle/10665/331226
  • Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C., Abiona, O., Graham, B. S., & McLellan, J. S. (2020). Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science, 367(6483), 1260–1263. https://doi.org/10.1126/science.abb2507
  • Xu, J., Zhao, S., Teng, T., Abdalla, A. E., Zhu, W., Xie, L., Wang, Y., & Guo, X. (2020). Systematic comparison of two animal-to-human transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV. Viruses, 12(2), 244. https://doi.org/10.3390/v12020244
  • Yamashita, F., & Hashida, M. (2004). In silico approaches for predicting ADME properties of drugs. Drug Metabolism and Pharmacokinetics, 19(5), 327–338. https://doi.org/10.2133/dmpk.19.327
  • Yang, H. T., Xie, W., Xue, X., Yang, K., Ma, J., Liang, W., Zhao, Q., Zhou, Z., Pei, D., Ziebuhr, J., & Hilgenfeld, R. (2005). Design of wide-spectrum inhibitors targeting coronavirus main proteases. Plos Biology, 3, 2044–2044.
  • Yang, H., Yang, M., Ding, Y., Liu, Y., Lou, Z., Zhou, Z., Sun, L., Mo, L., Ye, S., Pang, H., Gao, G. F., Anand, K., Bartlam, M., Hilgenfeld, R., & Rao, Z. (2003). The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proceedings of the National Academy of Sciences of the United States of America, 100(23), 13190–13195. https://doi.org/10.1073/pnas.1835675100
  • Yang, Z., Lasker, K., Schneidman-Duhovny, D., Webb, B., Huang, C. C., Pettersen, E. F., Goddard, T. D., Meng, E. C., Sali, A., & Ferrin, T. E. (2012). UCSF Chimera, MODELLER, and IMP: An integrated modeling system. Journal of Structural Biology, 179(3), 269–278. https://doi.org/10.1016/j.jsb.2011.09.006
  • Ylilauri, M., & Pentikäinen, O. T. (2013). MMGBSA as a tool to understand the binding affinities of filamin-peptide interactions. Journal of Chemical Information and Modeling, 53(10), 2626–2633. https://doi.org/10.1021/ci4002475
  • Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., Tan, W; China Novel Coronavirus Investigating and Research Team. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine, 382(8), 727–733.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.